Advertisement

Addiction Treatment

Lebanon, N.H.-based Dartmouth Health’s Dartmouth Hitchcock Medical Center is launching a dedicated inpatient program for pregnant patients with substance use disorders, with plans to double patient capacity within the program’s first year. The health system said the program is the…

West Orange, N.J.-based RWJBarnabas is expanding its hospital-based naloxone distribution initiative statewide through its Institute for Prevention and Recovery, with the goal of distributing more than 15,000 naloxone kits and wellness bags across New Jersey.  The initiative will distribute kits…

Spokane, Wash.-based MultiCare Deaconess Hospital has administered a long-acting buprenorphine 19 times since launching a pilot program in February 2025 aimed at treating patients experiencing opioid overdose or withdrawal. The injectable medication provides up to five days of symptom relief…

Anchorage, Alaska, has launched a municipal addiction treatment program that pairs housing with addiction care through a microunit model, Alaska Public Media reported April 7. The program, called Willow Commons, opened in late March and includes 32 individual units for…

Advertisement

The American Society of Addiction Medicine has released a new volume of the ASAM Criteria establishing dedicated treatment standards and admission criteria for adolescents and transition-age youths with substance use disorder. “Adolescents and Transition-Aged Youth” is part of the fourth…

The Foundation for Opioid Response Efforts has outlined strategies to expand prevention, treatment and recovery services for opioid use disorder in rural communities.  The brief draws on lessons from 10 programs funded by the nonprofit organization and is intended to…

Recovery Centers of America’s Monroeville, Pa., site has made recovery housing a central part of its growth strategy, aiming to stabilize patients during the critical transition from residential treatment back into daily life.  David Blenk, CEO of RCA at Monroeville,…

GLP-1 receptor agonists may reduce the risk of developing and dying from substance use disorders, a study found. The study, led by researchers at St. Louis-based WashU Medicine and published March 4 in The BMJ, analyzed data from more than…

Advertisement